| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 300.85M | 302.07M | 403.64M | 304.01M | 300.42M | 239.38M |
| Gross Profit | 62.14M | 62.13M | 80.32M | 63.42M | 27.80M | 4.84M |
| EBITDA | 12.81M | 13.94M | 9.04M | 7.66M | -46.50M | -46.83M |
| Net Income | -693.73K | 1.15M | 2.77M | -2.22M | -52.27M | -42.82M |
Balance Sheet | ||||||
| Total Assets | 1.03B | 1.00B | 995.77M | 1.02B | 1.00B | 1.05B |
| Cash, Cash Equivalents and Short-Term Investments | 431.80M | 440.79M | 373.61M | 485.37M | 478.37M | 424.80M |
| Total Debt | 0.00 | 4.22M | 4.63M | 4.82M | 5.12M | 6.18M |
| Total Liabilities | 160.02M | 137.86M | 130.69M | 174.41M | 165.75M | 156.58M |
| Stockholders Equity | 779.32M | 778.34M | 776.65M | 755.85M | 754.88M | 805.27M |
Cash Flow | ||||||
| Free Cash Flow | -36.52M | 65.90M | -133.25M | -24.20M | 47.54M | -8.97M |
| Operating Cash Flow | -12.70M | 86.13M | -120.21M | -22.66M | 48.48M | -5.77M |
| Investing Cash Flow | -23.96M | -18.36M | 15.03M | 29.85M | 15.99M | 20.51M |
| Financing Cash Flow | -4.32M | -512.44K | -531.40K | -502.97K | -546.84K | -4.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | HK$169.13M | 2.54 | 7.40% | ― | -9.34% | 605.26% | |
58 Neutral | HK$619.25M | -9.93 | -3.08% | ― | 5.24% | -201.60% | |
52 Neutral | HK$360.00M | -468.42 | -0.09% | ― | -23.93% | -109.41% | |
50 Neutral | HK$51.06M | -1.78 | -14.69% | ― | -43.22% | -34.69% | |
49 Neutral | HK$228.80M | -2.66 | -24.22% | ― | -20.95% | -13.14% | |
41 Neutral | HK$106.05M | -0.83 | -29.56% | ― | -12.03% | -40.38% |
Chengdu SIWI Science and Technology Company Limited has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The company has also established four committees to oversee various aspects of its governance, including remuneration, nomination, audit, and strategic development, with specific directors assigned to each committee. This announcement highlights the company’s commitment to structured governance and strategic oversight, which may enhance its operational efficiency and strengthen its position in the industry.
Chengdu SIWI Science and Technology Company Limited plans to use its reserves to offset accumulated losses of RMB272 million, reducing them to zero. This financial maneuver aims to enhance investor returns and support the company’s high-quality development, pending shareholder approval at the upcoming general meeting.
Chengdu SIWI Science and Technology Company Limited has announced its 2025 second extraordinary general meeting, which will address key resolutions including using reserves to offset company losses and the election of a new non-executive director, Mr. Li Qiangbin. This meeting is significant for the company’s governance and financial strategy, potentially impacting shareholder interests and the company’s market positioning.
Chengdu Siwi Science and Technology Company Limited, through its subsidiary SEI Optical, has renewed its agreement with Sumitomo Electric Group for the supply of optical fibre preforms and related equipment, spare parts, and technical services. This renewal, effective from January 1, 2026, to December 31, 2026, ensures the continuation of business operations with Sumitomo Electric, a substantial shareholder and connected person under the Listing Rules. The agreement’s terms have been deemed fair and reasonable by the company’s directors and independent non-executive directors, aligning with normal commercial practices and market prices, thus exempting it from certain regulatory requirements.
Chengdu SIWI Science and Technology Company Limited, a sino-foreign joint stock company in China, has renewed its agreement with the 29th Research Institute for the supply of accessories, cables, and cable joints for high and low frequency components. The renewal of the 29th Research Institute Supply Framework Agreement, effective from January 1, 2026, to December 31, 2026, continues the company’s ongoing transactions with its indirect controlling shareholder. These transactions are considered continuing connected transactions under Hong Kong’s Listing Rules, subject to reporting and annual review but exempt from independent shareholders’ approval.
Chengdu Putian Telecommunications Cable Co., Ltd. has announced a revision of the annual cap for its continuing connected transactions under the 2025 Seekon Microwave Supply Framework Agreement. The company anticipates increased demand due to business development and expansion, prompting a revision of the existing annual cap to RMB5 million for the financial year ending December 31, 2025. Additionally, the company has entered into the 2026 Seekon Microwave Supply Framework Agreement to continue supplying accessories, optic products, and related services to Seekon Microwave from January 1, 2026, to December 31, 2026. These transactions are subject to reporting, annual review, and announcement requirements under the Listing Rules, but are exempt from independent shareholders’ approval.
Chengdu Putian Telecommunications Cable Co., Ltd. has announced the renewal of its supply framework agreement with the 8th Research Institute, a subsidiary of China Electronics Technology, for the year 2026. This agreement involves SEI Optical, a subsidiary of the company, supplying optical fibre products to the 8th Research Institute. The transactions are classified as continuing connected transactions under Hong Kong’s Listing Rules, requiring reporting and annual review but exempt from independent shareholders’ approval. The agreement is set for a fixed term from January 1, 2026, to December 31, 2026, with pricing based on prevailing market conditions.
Chengdu Siwi Science and Technology Company Limited has announced a revision to its annual cap for continuing connected transactions under the 2025 23rd Research Institute Supply Framework Agreement. The company anticipates that its demand for accessories, cables, and cable joints will exceed previous projections, prompting an increase in the annual cap to RMB14 million for the year ending December 31, 2025. Additionally, the company has entered into a new agreement with the 23rd Research Institute for the supply of these components for the year 2026, ensuring continuity of supply and operations.
Chengdu Putian Telecommunications Cable Co., Ltd. has entered into a Supply Framework Agreement with the 51st Research Institute, a subsidiary of China Electronics Technology, to supply optical cable assemblies and optical device sub-modules from November 2025 to December 2026. This agreement constitutes continuing connected transactions under Hong Kong’s Listing Rules, requiring reporting and annual review but exempting independent shareholders’ approval. The pricing will be based on prevailing market rates, ensuring competitiveness and alignment with market conditions.
Chengdu Siwi Science and Technology Company Limited, a sino-foreign joint stock company in China, has entered into a Sales Framework Agreement with the 23rd Research Institute, a subsidiary of China Electronics Technology. This agreement involves the supply of components, optic products, and related services for one year starting January 2026. The transactions are considered continuing connected transactions under Hong Kong’s Listing Rules, requiring reporting and annual review but exempt from independent shareholder approval. The pricing will be based on market rates, ensuring terms are comparable to those offered to independent third parties.
Chengdu Siwi Science and Technology Company Limited has entered into a Siwi High Tech Framework Purchase Agreement with Siwi High Tech, a direct controlling shareholder, to purchase accessories, cables, and cable joints for high and low frequency components. This agreement, effective from January 1, 2026, to December 31, 2026, is categorized as a continuing connected transaction under Hong Kong’s Listing Rules. The transaction is subject to reporting and annual review but is exempt from independent shareholder approval due to the applicable percentage ratios. The pricing and payment terms will be negotiated on an arm’s length basis, ensuring they are no less favorable than market levels.
Chengdu SIWI Science and Technology Company Limited, a sino-foreign joint stock company, announced a change in its principal place of business in Hong Kong. The new address will be effective from November 27, 2025, indicating a strategic move that may impact its operational logistics and stakeholder engagements.
Chengdu Siwi Science and Technology Company Limited has issued a supplemental announcement regarding the emoluments paid to its Directors, Independent Non-Executive Directors, and Supervisors for the years 2008 to 2013. The announcement provides additional information on the remuneration structure, including salaries, allowances, and performance-related incentives, while noting that the overall information in the annual reports remains unchanged. This update may impact stakeholders’ understanding of the company’s financial disclosures and governance practices.
Chengdu SIWI Science and Technology Company Limited announced changes in its board of directors, with Mr. Chan Wei resigning as a non-executive director and member of the Remuneration and Appraisal Committee, and Mr. Li Qiangbin being appointed to the same positions. This transition, effective from November 27, 2025, is part of the company’s ongoing governance adjustments, potentially impacting its strategic direction and stakeholder relations.
Chengdu SIWI Science and Technology Company Limited announced an extension of the public tender period for the potential disposal of its 100% equity interests in its subsidiary, Putian New Material. The initial tender period ended without any bids, prompting the company to extend the period under the same conditions for up to twelve months. The disposal has not yet materialized, and stakeholders are advised to exercise caution as the process continues.